Related Experiment Video
Updated: Jul 11, 2025

07:24
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.7K
Microsurgery in the Sickle Cell Trait Population: Can it Be Safely and Successfully Performed?
Sara Eliseo1, Levana Berlin2, Ahmed M Mansour2
1From Philadelphia College of Osteopathic Medicine, Moultrie, Ga.
Plastic and Reconstructive Surgery. Global Open
|November 9, 2023
Summary
Microsurgery for breast reconstruction is feasible in patients with sickle cell trait (SCT). This case study demonstrates successful deep inferior epigastric perforator free-tissue transfer in an SCT patient, expanding evidence for autologous reconstruction safety.
Area of Science:
- Plastic Surgery
- Vascular Surgery
- Hematology
Background:
- Free-tissue transfer reconstruction in sickle cell anemia patients carries risks due to sickle hemoglobin polymerization in flap microcirculation.
- Most literature focuses on sickle cell disease, a contraindication for microsurgery, with fewer reports on sickle cell trait (SCT).
Observation:
- A 52-year-old woman with SCT underwent deep inferior epigastric perforator (DIEP) free-tissue transfer for breast reconstruction after failed alloplastic reconstruction.
- Postoperative Doppler confirmed patent arterial and venous anastomoses. Blistering and partial flap necrosis occurred on postoperative days 8 and 15, respectively.
- Debridement and closure successfully managed flap complications; the flap remained well-perfused and incorporated at 5 months.
Findings:
- This case reports a successful microsurgical breast reconstruction using DIEP free-tissue transfer in a patient with sickle cell trait (SCT).
- The patient experienced minor flap complications (blistering, partial necrosis) that were successfully managed, with a good long-term outcome.
Implications:
- This case expands the limited evidence supporting the safety and feasibility of autologous microsurgical reconstruction in patients with the heterozygous sickle cell trait phenotype.
- Highlights the potential for successful free-tissue transfer in select patients with sickle cell trait, challenging previous contraindications.

